Navigation Links
New mouse model points to therapy for liver disease
Date:8/18/2014

Non-alcoholic fatty liver disease (NAFLD) is a common affliction, affecting almost 30 percent of Americans, with a significant number suffering from its most severe form, called non-alcoholic steatohepatitis or NASH, which can lead to cirrhosis and liver cancer. In recent years, NASH has become the leading cause of liver transplantation.

Development of effective new therapies for preventing or treating NASH has been stymied by limited small animal models for the disease. In a paper published online in Cancer Cell, scientists at the University of California, San Diego School of Medicine describe a novel mouse model that closely resembles human NASH and use it to demonstrate that interference with a key inflammatory protein inhibits both the development of NASH and its progression to liver cancer.

"These findings strongly call for clinical testing of relevant drugs in human NASH and its complications," said senior author Michael Karin, PhD, Distinguished Professor of Pharmacology in UC San Diego's Laboratory of Gene Regulation and Signal Transduction. "Our research has shown that, at least in this mouse model, chemical compounds that include already clinically approved drugs that inhibit protein aggregation can also be used to prevent NASH caused by a high fat diet."

The increasing prevalence of NAFLD is linked to the nation's on-going obesity epidemic. In the past decade, the rate of obesity has doubled in adults and tripled in children, in large part due to a common diet rich in simple carbohydrates and saturated fats. NASH is characterized by inflammation and fibrosis, which damage the liver and can lead to cirrhosis, hepatocellular carcinoma (HCC), the major form of liver cancer, and loss of function. Often, the only remedy is organ transplantation.

"Developing new strategies for NASH that successfully block progression to cirrhosis or HCC required the creation of appropriate small animal models that are amenable to genetic analysis and therapeutic intervention," said first author Hayato Nakagawa, PhD, a member of Karin's lab who headed the research effort and is currently an assistant professor at the University of Tokyo School of Medicine.

The resulting new mouse model takes advantage of an existing mouse strain called MUP-uPA that develops liver damage similar to humans when fed a high-fat diet (in which 60 percent of calories are fat derived) similar to the so-called "American cafeteria diet." The mice show clinical signs characteristic of NASH within 24 weeks and full-blown HCC after 40 weeks. "The pathological characteristics of these tumors are nearly identical to those of human HCC," said Nakagawa.

Using the new mouse model, Nakagawa and colleagues showed that a protein called tumor necrosis factor (TNF), involved in the body's inflammatory response, plays a critical role in both NASH pathogenesis and progression to fibrosis and HCC. By interfering with TNF synthesis or its binding to its receptor, using genetic tools or an anti-psoriasis and rheumatoid arthritis drug called Enbrel, the researchers inhibited both development of NASH and its progression to HCC in the mouse model.

"Given the dramatic and persistent increase in the incidence of obesity and its consequences in the United States and elsewhere, these studies have a high impact on a major public health problem. In addition to developing a more suitable model for the study of NASH, this new work suggests some immediate targets for prevention and therapeutic intervention," said Karin, who is an American Cancer Society Research Professor and holds the Ben and Wanda Hildyard Chair for Mitochondrial and Metabolic Diseases.


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related medicine news :

1. Potential drug therapy for kidney stones identified in mouse study
2. Insular cortex alterations in mouse models of autism
3. Supermodel mouse reveals mechanisms that regulate metabolism, researchers find
4. Mouse study offers new clues to cognitive decline
5. A novel transgenic mouse model of Chinese Charcot-Marie-Tooth disease type 2L
6. A versatile mouse that can teach us about many diseases and drugs
7. Building a better mouse model to understand pancreatic cancer
8. Researchers identify fundamental differences between human cancers and genetically engineered mouse models of cancer
9. Heated Mouse: Introducing ValueRays® Executive Series Heated Computer Mice
10. Knockout mouse grows larger, but weaker, muscles
11. UCLA and Chinese scientists analyze genetic makeup of human and mouse embryos in amazing detail
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2020)... MESA, Calif. (PRWEB) , ... September 01, 2020 , ... ... the “safe side”, the Cohn Health Institute has taken this time to ... In celebration of its 30th Anniversary, the Cohn Health Institute will be relaunching its ...
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean Springs, ... masks to medical first responders across the United States. Since the start of ... protective equipment (PPE) medical centers , hospitals , firefighters , ...
(Date:8/31/2020)... ... 31, 2020 , ... The pandemic and topsy-turvy economic outlook continues to put financial strain on ... ways to trim the fat from our monthly expenses and put more into savings, if ... that you have a financial safety net in place in case something were to happen ...
(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author Randy Pausch was diagnosed ... people would. Rather than become melancholic, however, he put together a final lecture in ... Randy Pausch took a negative situation and turned it into something that inspired millions ...
(Date:8/28/2020)... ... August 28, 2020 , ... Integrated Viral Protection ... the first Florida school to deploy its breakthrough Mobile Biodefense Indoor Air Protection System ... True North Classical Academy plans to fully reopen equipped with the filtration system on ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... N.C. (PRWEB) , ... August 27, 2020 , ... Bleep ... football player and sleep apnea patient, is the company’s new spokesperson. , “In my ... football field. So, when I found the Bleep DreamPort it was a Bleeping no ...
(Date:8/26/2020)... , ... August 26, 2020 , ... ... Chiropractic Care Helps Sports Injuries. The infographic breaks down ways that chiropractors can ... healthier recovery. , According to ScripHessco “Athletes have an unusual amount of pressure ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... that it has entered into definitive agreement to acquire ProCE, a nationally ... pharmacists and pharmacy technicians. , CEA represents a growing alliance of ...
Breaking Medicine Technology: